The next stage of revalidation is coming, here are some vital tools to help you prepare.
Should the pharmacy degree be five years long?Subscription
The General Pharmaceutical Council has proposed radical changes to pharmacy education, but not everyone agrees that it has found the best way forward. Berwyn Owen and Nigel Ratcliffe give arguments for and against.
A step-by-step guide for pharmacists and pharmacy technicians to undertaking and documenting this vital part of revalidation, according to General Pharmaceutical Council requirements.
A step-by-step guide for pharmacists and pharmacy technicians to writing and submitting this vital part of revalidation to General Pharmaceutical Council requirements.
Chief pharmacist Graham Parsons details a typical day working for the leading social enterprise, Turning Point, which supports clients with learning disabilities, mental health, and drug and alcohol problems.
The co-chief operating officer of Walgreens Boots Alliance discusses her humble beginnings in community pharmacy and how she transformed her pharmaceutical distribution company into a global organisation employing more than 400,000 people.
The Pharmaceutical Services Negotiating Committee has warned against the government’s suggestion that a centralised system is the “desired future approach” to procuring specials.
NHS patients have accrued a total debt of £246m in unpaid penalty fees for incorrectly claiming free NHS prescriptions, the National Audit Office has said.
A legal campaign group has said pharmacists are “unqualified” to dispense alternative medicines during shortages in line with a government-issued protocol.
A scheme to help primary healthcare teams support lesbian, gay, bisexual and transsexual people has expanded to London.
The Advisory Council on the Misuse of Drugs (ACMD) has been asked to provide an outline framework on medical cannabis by the end of 2019, with the aim of having an initial view by the end of 2020.
Specialist pharmacists across 23 areas in England will help to identify patients with atrial fibrillation who are at risk of stroke and could benefit from medication, under a £9m programme announced by NHS England.